Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kristoffer Nilsson"'
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 54-64 (2024)
Abstract Aims We aimed to examine cardiovascular events (stroke and myocardial infarction [MI]), mortality, early retirement and economic costs over 5 years in people with chronic heart failure (CHF) and matched controls in Sweden. Methods and result
Externí odkaz:
https://doaj.org/article/c23747a09ef14e5eae66b6bc5ecce985
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Aim To examine direct and indirect costs, early retirement, cardiovascular events and mortality over 5 years in people with atherosclerotic cardiovascular disease (ASCVD) and matched controls in Sweden. Methods Individuals aged ≥ 16 years
Externí odkaz:
https://doaj.org/article/5637987885cd468780e83da89a807c5c
Autor:
Chinmay Dwibedi, Emelia Mellergård, Amaru Cuba Gyllensten, Kristoffer Nilsson, Annika S. Axelsson, Malin Bäckman, Magnus Sahlgren, Stephen H. Friend, Sofie Persson, Stefan Franzén, Birgitta Abrahamsson, Katarina Steen Carlsson, Anders H. Rosengren
Publikováno v:
npj Digital Medicine, Vol 5, Iss 1, Pp 1-13 (2022)
Abstract The lack of effective, scalable solutions for lifestyle treatment is a global clinical problem, causing severe morbidity and mortality. We developed a method for lifestyle treatment that promotes self-reflection and iterative behavioral chan
Externí odkaz:
https://doaj.org/article/b90905104ae444b2b4399e54f50a16f2
Autor:
Michał Kunc, Anna Gabrych, Dominika Dulak, Karolina Hasko, Malgorzata Styczewska, Dagmara Szmyd, Kristoffer Nilsson, Marek Iwinski, Agata Sobocińska-Mirska, Malgorzata Sawicka-Zukowska, Malgorzata A. Krawczyk, Ewa Bien
Publikováno v:
Archives of Medical Science, Vol 18, Iss 5, Pp 1253-1261 (2021)
Introduction Markers of inflammation such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) have been found to be associated with survival in cancer patients. The aim of the current st
Externí odkaz:
https://doaj.org/article/4e9459e44fb34bf08378ac8dea5da802
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 7, Iss 1 (2020)
**Background:** In order to facilitate sound economic evaluations of novel treatments, health-economic models of polycythemia vera (PV) must combine effects on surrogate endpoints in trials with disease progression (DP) and mortality in long-term coh
Externí odkaz:
https://doaj.org/article/61b7366a7d344ab1a541e664f07c4df8
Autor:
Sofie Persson, Kristoffer Nilsson, Kristina Karlsdotter, Josefin Skogsberg, Staffan Gustavsson, Johan Jendle, Katarina Steen Carlsson
Publikováno v:
Diabetes, Obesity and Metabolism. 25:726-734
To assess hospital-based care, work absence, associated costs, and mortality in patients with type 2 diabetes with and without established cardiovascular disease (eCVD) compared to matched controls.In a population-based cohort study, we analysed indi
Autor:
null Kristoffer Nilsson, null Emelie Andersson, null Sofie Persson, null Kristina Karlsdotter, null Josefin Skogsberg, null Staffan Gustavsson, null Johan Jendle, null Katarina Steen Carlsson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88a4fe468355704556d95dfba670ecee
https://doi.org/10.1111/dom.14921/v2/response1
https://doi.org/10.1111/dom.14921/v2/response1
Autor:
null Sofie Persson, null Kristoffer Nilsson, null Kristina Karlsdotter, null Josefin Skogsberg, null Staffan Gustavsson, null Johan Jendle, null Katarina Steen Carlsson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::380a77b3ed51519b78069c79ac53f6cf
https://doi.org/10.1111/dom.14919/v2/response1
https://doi.org/10.1111/dom.14919/v2/response1
Autor:
Kristoffer Nilsson, Emelie Andersson, Sofie Persson, Kristina Karlsdotter, Josefin Skogsberg, Staffan Gustavsson, Johan Jendle, Katarina Steen Carlsson
Publikováno v:
Diabetes, obesitymetabolismREFERENCES.
To perform a model-based analysis of the short- and long-term health benefits and costs of further increased implementation of empagliflozin for people with type 2 diabetes and established cardiovascular disease (eCVD) in Sweden.The validated Institu
Publikováno v:
Journal of Health Economics and Outcomes Research
**Background:** In order to facilitate sound economic evaluations of novel treatments, health-economic models of polycythemia vera (PV) must combine effects on surrogate endpoints in trials with disease progression (DP) and mortality in long-term coh